Empirical Financial Services, LLC d.b.a. Empirical Wealth Management
Position in ACAD — Acadia Pharmaceuticals Inc
CIK 1510434
Seattle, WA
Position in ACAD
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$391,871
+$104,206 QoQ
Shares Held
15,489
+19.9% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#211
of 350 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Empirical Financial Services, LLC d.b.a. Empirical Wealth Management holds $12,687,043 across 17 Biotechnology names. ACAD ranks #8 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | 73,041 | $2,295,678 | |||
| 2 | INBX |
Inhibrx Biosciences, Inc.
|
22,584 | $2,139,834 | |
| 3 | ORKA |
Oruka Therapeutics, Inc.
|
19,312 | $1,837,923 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
7,464 | $1,798,599 | |
| 5 | PTCT |
Ptc Therapeutics, Inc.
|
15,916 | $1,298,267 | |
| 6 | EXEL |
Exelixis, Inc.
|
10,083 | $548,615 | |
| 7 | HRMY |
Harmony Biosciences Holdings, Inc.
|
11,831 | $430,766 | |
| 8 | ACAD |
Acadia Pharmaceuticals Inc
This page
|
15,489 | $391,871 |
All Filings in ACAD
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $391,871 | 15,489 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $287,665 | 12,923 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $264,348 | 9,897 | Shares | Sole | 2026-01-16 | |
| No filing history on record for this holder in this stock. | ||||||